57 results on '"van der Burg, Sjoerd"'
Search Results
2. Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy
3. The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent
4. Neoantigen-directed therapeutics in the clinic: where are we?
5. A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma
6. Challenges in neoantigen-directed therapeutics
7. Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment
8. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes
9. Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses
10. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
11. NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
12. Correlates of immune and clinical activity of novel cancer vaccines
13. Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance
14. Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors
15. Control of immune escaped human papilloma virus is regained after therapeutic vaccination
16. New approaches in vaccine-based immunotherapy for human papillomavirus-induced cancer
17. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
18. CD40-Mediated Amplification of Local Immunity by Epithelial Cells Is Impaired by HPV
19. Dominant contribution of the proteasome and metalloproteinases to TAP-independent MHC-I peptide repertoire
20. Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer
21. Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2
22. Therapy of Human Papillomavirus-Related Disease
23. Immunotherapy for persistent viral infections and associated disease
24. Therapeutic vaccination against human papilloma virus induced malignancies
25. Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells
26. Tumor-specific regulatory T cells in cancer patients
27. The effect of neoadjuvant chemoradiotherapy on the immune profile of pancreatic ductal adenocarcinoma: in-depth analysis of the PREOPANC-1 randomised controlled trial
28. Distinct Uptake Mechanisms but Similar Intracellular Processing of Two Different Toll-like Receptor Ligand-Peptide Conjugates in Dendritic Cells
29. Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists
30. Chapter Ten - Generation of TCR-engineered reference cell samples to control T-cell assay performance
31. The effect of neoadjuvant chemoradiotherapy on the immune profile of pancreatic ductal adenocarcinoma: In-depth analysis of the PREOPANC-1 randomized controlled trial
32. Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy
33. Vaccination for Treatment and Prevention of Cancer in Animal Models
34. Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML Patients Correlates with Clinical Response and MRD Conversion
35. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
36. Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides
37. The status of HPV16-specific T-cell reactivity in health and disease as a guide to HPV vaccine development
38. Design and evaluation of antigen-specific vaccination strategies against cancer
39. Strategies for immunotherapy of cancer
40. The role of the reporting framework MIATA within current efforts to advance immune monitoring
41. Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma.
42. Chapter 16 - Comprehensive Immunomonitoring to Guide the Development of Immunotherapeutic Products for Cancer
43. Chapter 3 - Mechanisms of Peptide Vaccination in Mouse Models: Tolerance, Immunity, and Hyperreactivity
44. About the editors
45. 2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation
46. Editorial overview: Tumour immunology: What's beyond today's success in tumor immunology
47. Synthesis of 2-alkoxy-8-hydroxyadenylpeptides: Towards synthetic epitope-based vaccines
48. Chemical synthesis of the HPV16 E7 protein
49. List of Contributors
50. Mechanism of superior cross-presentation of synthetic long peptides in comparison with protein for therapeutic cancer vaccination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.